Variant report
Variant | nsv510591 |
---|---|
Chromosome Location | chr13:63598573-63608412 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147500272 | chr13:63598591-63598592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs183048238 | chr13:63598601-63598602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187323184 | chr13:63598636-63598637 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs578101907 | chr13:63598691-63598692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545431997 | chr13:63598714-63598715 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563641834 | chr13:63598776-63598777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531124104 | chr13:63598838-63598839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548645854 | chr13:63598843-63598844 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543289331 | chr13:63598885-63598886 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2780366 | chr13:63598906-63598907 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs528681091 | chr13:63598920-63598921 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537435684 | chr13:63598968-63598969 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546329070 | chr13:63598995-63598996 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs371614997 | chr13:63599045-63599046 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532032595 | chr13:63599063-63599064 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs35062654 | chr13:63599155-63599156 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140120205 | chr13:63599250-63599251 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs571383753 | chr13:63599275-63599276 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568801776 | chr13:63599276-63599277 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536188806 | chr13:63599277-63599278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2669331 | chr13:63599278-63599279 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs200682943 | chr13:63599289-63599290 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs118070044 | chr13:63599297-63599298 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552862270 | chr13:63599336-63599337 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs150871941 | chr13:63599360-63599361 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534270327 | chr13:63599361-63599362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572909172 | chr13:63599372-63599373 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533983329 | chr13:63599373-63599374 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558746943 | chr13:63599397-63599398 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs191774372 | chr13:63599409-63599410 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545480915 | chr13:63599434-63599435 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535226380 | chr13:63599437-63599438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557424106 | chr13:63599545-63599546 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs2780367 | chr13:63599547-63599548 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs145424839 | chr13:63599549-63599550 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184643894 | chr13:63599555-63599556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188934909 | chr13:63599575-63599576 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540429691 | chr13:63599593-63599594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565109163 | chr13:63599611-63599612 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs193120681 | chr13:63599660-63599661 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550247634 | chr13:63599701-63599702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568789886 | chr13:63599704-63599705 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529692115 | chr13:63599718-63599719 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185497406 | chr13:63599743-63599744 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543765319 | chr13:63599755-63599756 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189203725 | chr13:63599920-63599921 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115815269 | chr13:63599995-63599996 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373806392 | chr13:63599996-63599997 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558798454 | chr13:63599997-63599998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570641997 | chr13:63600052-63600053 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:63597800-63600400 | Weak transcription | Brain Anterior Caudate | brain |
2 | chr13:63598600-63598800 | Enhancers | Brain Hippocampus Middle | brain |
3 | chr13:63598800-63601000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr13:63599000-63600000 | Weak transcription | Brain Hippocampus Middle | brain |
5 | chr13:63599600-63600800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr13:63600000-63600400 | Active TSS | Brain Hippocampus Middle | brain |
7 | chr13:63600000-63600800 | Enhancers | Brain Cingulate Gyrus | brain |
8 | chr13:63600400-63600600 | Enhancers | Brain Anterior Caudate | brain |
9 | chr13:63600400-63600800 | Enhancers | Brain Hippocampus Middle | brain |
10 | chr13:63600600-63600800 | Flanking Active TSS | Brain Anterior Caudate | brain |
11 | chr13:63600600-63600800 | Enhancers | Brain Inferior Temporal Lobe | brain |
12 | chr13:63600600-63600800 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
13 | chr13:63600600-63600800 | Enhancers | Brain Substantia Nigra | brain |